Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis

Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney

(2011) C. A. Hutchison et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study

(2010) Heinz Ludwig et al.   JOURNAL OF CLINICAL ONCOLOGY

Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents

(2010) Maria Roussou et al.   LEUKEMIA RESEARCH

Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis

(2009) C. A. Hutchison et al.   Clinical Journal of the American Society of Nephrology

Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre

(2009) R. J. Haynes et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum Free-Light Chain Removal by High Cutoff Hemodialysis: Optimizing Removal and Supportive Care

(2008) Colin A. Hutchison et al.   ARTIFICIAL ORGANS

Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease

(2008) C. A. Hutchison et al.   Clinical Journal of the American Society of Nephrology

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

(2008) N. Leung et al.   KIDNEY INTERNATIONAL

European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial

(2008) Colin A Hutchison et al.   Trials